AvH renews authorised capital: 21.8% flexibility, not an announced dilution

Ackermans & van Haaren has called an extraordinary meeting for 15 October 2026 to renew its board's authorised capital for five years. The requested ceiling is €500,000 of nominal value. That equals 21.8% of current statutory capital, but it does not mean a 21.8% dilution has been decided.

Why AvH shareholders should care: authorised capital gives the board flexibility to fund an acquisition, use shares as transaction consideration or respond to market circumstances without immediately convening a separate meeting for every issue.

AvH is a Belgian investment holding company allocating capital across private banking, marine engineering, real estate, energy and growth investments. The ability to issue shares therefore touches directly on how future transactions at the parent-company level could be financed.

The 21.8% calculation compares two nominal amounts: the requested €500,000 divided by €2,295,278 of statutory capital. Nominal capital is a legal measure attached to the shares. It is neither the cash AvH would receive nor their market value. An actual issue would still require a board decision, a share count, a price and terms.

The notice also renews authorities concerning treasury shares and provides for authorised capital to be used for three years in the context of a public offer. Those clauses increase the board's defensive flexibility; they prove neither a pending bid nor an imminent acquisition.

The documents reviewed provide for physical attendance or proxy representation. They do not announce online participation.